Blumberg Capital

It is the How we do. What we do. Innovation is an all-encompassing imperative.

Home > Archives for Blumberg Capital
From Series A to Celebrating BioCatch’s Next Chapter with Visa
From Series A to Celebrating BioCatch’s Next Chapter with Visa
Visa to Buy Fraud Defense Platform BioCatch in $2.4 Billion Deal
Visa to Buy Fraud Defense Platform BioCatch in $2.4 Billion Deal
Why Venture Capital Is Really About Risk Minimization
Why Venture Capital Is Really About Risk Minimization
post-image
Top AI Startups to Watch in 2026
Top AI Startups to Watch in 2026
AI Startups in Miami to Follow in 2026
AI Startups in Miami to Follow in 2026
What Investors Really Want From AI Founders Now
What Investors Really Want From AI Founders Now
How AI is Revamping Manufacturing Inspection: Q&A with Overview AI CEO Christopher Van Dyke
How AI is Revamping Manufacturing Inspection: Q&A with Overview AI CEO Christopher Van Dyke
post-image
The most innovative healthcare companies of 2026
The most innovative healthcare companies of 2026
AI Is Turning Contact Centers Into Growth Engines
AI Is Turning Contact Centers Into Growth Engines
Recent
September 21, 2026
Why We Continue to Back Angle: Angle Health Raises $600M at a $2.7B Valuation
September 18, 2026
The Wall Street Journal: AI Startup Angle Health Lands $600 Million for $2.7 Billion Valuation
September 15, 2026
Beyond Startup Nation: Building Israel’s Next Technology Advantage
August 4, 2026
From Series A to Celebrating BioCatch’s Next Chapter with Visa
August 3, 2026
Visa to Buy Fraud Defense Platform BioCatch in $2.4 Billion Deal
July 27, 2026
Where Is the Long-Term Value in Your AI Startup?